Surgery News and Research

RSS

Mayo Clinic to offer novel device for patients with GERD

Mayo Clinic in Florida will be one of the first health care institutions in the United States to offer a newly approved device to treat gastroesophageal reflux disease (GERD). The condition, also known as acid reflux disease, can lead to serious health problems.

12 Apr 2012

Viewpoints: 'Slicing' the safety net; GOP health law fight should have targeted cost-cutting panel, not mandate

Last month, the House passed a 2013 budget written by Representative Paul Ryan of Wisconsin that would reduce spending in the category of Education, Training, Employment and Social Services by $16 billion from the previous year, or 22 percent, on top of all the cuts forced by Republicans over several years.

11 Apr 2012

USPTO issues five patents to VertiFlex Superion ISS

VertiFlex, Inc., a leading innovator of advanced minimally invasive spinal surgery technologies, today announced that the U.S. Patent and Trademark Office has awarded five additional key patents covering the design and implantation method for its unique interspinous spacer technology. The five U.S. patent numbers are 8,012,207, 8,123,807, 8,123,782, 8,128,662, and 8,152,837.

11 Apr 2012

NYU Langone announces opening of Center for Musculoskeletal Care

NYU Langone Medical Center ushered in the next generation of orthopaedic, rheumatologic and rehabilitative care with the opening of the Center for Musculoskeletal Care (CMC) at 333 East 38th Street in Manhattan last week.

11 Apr 2012

Oxytocin may offer hope for male sexual dysfunction

The hormone oxytocin that is also called the “love hormone” since it plays a role in the bond between a mother and baby may also improve sexual function - at least in men with Asperger’s syndrome - according to a published case report.

10 Apr 2012

Soon a vaccine that targets 90% of all cancers

Results from the safety trial - on patients with blood cancer - found all had greater immunity to the disease after receiving the vaccine. Three of the seven patients who have completed the treatment are now free of the condition.

10 Apr 2012

Omeros initiates enrollment in second Phase 3 trial of OMS302

Omeros Corporation today announced that patient enrollment has begun in the Company's second Phase 3 clinical trial evaluating OMS302 in intraocular lens replacement (ILR) surgery.

10 Apr 2012

Viewpoints: Doctors' efforts to cut unnecessary procedures is a good first step

Several news outlets look at the initiative by nine physicians' groups to identify medical procedures which are frequently unneeded and could even be harmful.

10 Apr 2012

UCSD surgeon implants new INX device in a 29-year old patient with GERD

On Monday, April 9, Santiago Horgan, MD, chief of minimally invasive surgery at UC San Diego Health System implanted the new FDA-approved LINX device in a 29-year old patient suffering from gastroesophageal reflux disease (GERD), a chronic digestive disease that can lead to severe inflammation, stricture, Barrett's esophagus and esophageal cancer.

10 Apr 2012

Three NJIT EDC high-tech companies win top awards at 2012 Venture Conference

Three high-tech companies based at NJIT's Enterprise Development Center (EDC) took top awards at the recent 2012 Venture Conference sponsored by the New Jersey Technology Council.

10 Apr 2012

Researchers determine that bacteria are present in the bladders of healthy women

Researchers have determined that bacteria are present in the bladders of some healthy women, which discredits the common belief that normal urine is sterile. These findings were published in the April issue of the Journal of Clinical Microbiology by researchers at Loyola University Chicago Stritch School of Medicine.

10 Apr 2012

ASPO to hold pediatric otolaryngology meeting from April 18 - April 22

The American Society of Pediatric Otolaryngology (ASPO) will hold its annual meeting, April 18 - April 22, during the 2012 Combined Otolaryngology Spring Meetings (COSM) - a joint meeting of eight otolaryngological societies in San Diego, CA. The meeting will feature dozens of scientific presentations highlighting research in progress in the field of otolaryngology-head and neck surgery.

10 Apr 2012

More than 60% of breast cancer survivors report post-treatment complications

More than 60 percent of breast cancer survivors report at least one treatment-related complication even six years after their diagnosis, according to a new study led by a researcher from the Perelman School of Medicine at the University of Pennsylvania.

10 Apr 2012

Changes in corneal thickness occur in patients at early stages of FECD

A national consortium of researchers has published new findings that could change the standard of practice for those treating Fuchs' Endothelial Corneal Dystrophy (FECD), a disease characterized by cornea swelling that can eventually lead to the need for corneal transplantation.

10 Apr 2012

Mayo Clinic introduces Breast Cancer Genome Guided Therapy Study

The Breast Cancer Genome Guided Therapy Study (BEAUTY Project) will help physicians tailor chemotherapy to breast cancer patients based on their individual genomes and the genomes of their tumors.

10 Apr 2012

UofL wins NIH grant for cardiac clinical research center

During his 18-year tenure at UofL, Dr. Roberto Bolli has generated more than $100 million in grants for basic research from the NIH. Today, Bolli joined with University of Louisville President James R. Ramsey to announce a new NIH grant he has won for clinical research, a seven-year, $3.4 million grant from the National Heart, Lung and Blood Institute to establish one of seven regional centers across the United States in the Cardiac Cell Therapy Research Network.

10 Apr 2012

Monitoring necessary for early intervention in Fuchs' Endothelial Corneal Dystrophy patients

10 Apr 2012

First Choice acquires FCMG

First Choice Healthcare Solutions, Inc. today announced its acquisition of First Choice Medical Group of Brevard, LLC, a multi-specialty medical group practice including orthopedics (both operative and non-operative), sports medicine, pain management and neurology located in Melbourne, Fla.

10 Apr 2012

Stealth announces results from three Bendavia Phase I clinical trials for mitochondrial dysfunction

Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative therapies for diseases with unmet medical needs, announced today the results from three Phase I clinical trials of Bendavia, a novel compound that targets the mitochondrion to treat mitochondrial dysfunction, including ischemia reperfusion and microvascular injury.

9 Apr 2012

Study shows causal effect of obesity on medical care costs

Obesity now accounts for almost 21 percent of U.S. health care costs - more than twice the previous estimates, reports a new Cornell University study.

9 Apr 2012